Table 1.
Overall (n = 62) | No upgrade (n = 52) | Upgrade (n = 10) | p value | |
---|---|---|---|---|
Age, mean ± SD, years | 54.7 ± 12.6 | 53.8 ± 12.6 | 59.7 ± 11.7 | 0.174 |
Menopausal status, n | 0.871 | |||
Premenopausal | 20 | 18 | 3 | |
Peri-/postmenopausal | 42 | 34 | 7 | |
Tumor size | ||||
Mean ± SD, mm | 11.5 ± 7.1 | 11.3 ± 7.0 | 12.3 ± 8.3 | 0.941 |
≥15 mm, n | 15 | 9 | 2 | 1.000 |
<15 mm, n | 47 | 43 | 8 | |
Distance to nipplea, mean ± SD, mm | 41.5 ± 27.6 | 36.8 ± 24.2 | 63.5 ± 32.8 | 0.012 |
Tumor characteristics, n | 0.808 | |||
Mass | 46 | 40 | 6 | |
Non-mass | 12 | 10 | 2 | |
Architectural distortion | 2 | 2 | 0 | |
Micro calcifications, n | 1.000 | |||
Yes | 8 | 7 | 1 | |
No | 54 | 35 | 9 | |
Initial BI-RADS category, n | 0.805 | |||
BI-RADS 3 | 4 | 4 | 0 | |
BI-RADS 4 | 54 | 46 | 8 | |
BI-RADS 5 | 4 | 2 | 2 | |
History of breast cancer in the contralateral breast, n | 0.629 | |||
Yes | 9 | 7 | 2 | |
No | 53 | 45 | 8 | |
Biopsy procedure, n | 1.000 | |||
CNB | 48 | 40 | 8 | |
VAB | 14 | 12 | 2 | |
Biopsy guidance, n | 0.901 | |||
US | 45 | 37 | 8 | |
MG | 12 | 10 | 2 | |
MRI | 5 | 5 | 0 |
Distance to the nipple in mm was significantly greater in lesions with an upgrade at excision, while the other characteristics did not reach significance.
SD = Standard deviation; CNB = core needle biopsy; VAB = vacuum-assisted biopsy; US = ultrasound; MG = mammography; MRI = magnetic resonance imaging.